Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Trillium Therapeutics Inc. TRIL
$18.44
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
20.96
-
week52low
5.80
-
Revenue
148000
-
P/E TTM
-26
-
Beta
1.90457700
-
EPS
0.00000000
-
Last Dividend
0.00000000
-
Next Earnings Date
12 ноя 2021 г. в 05:00
Описание компании
Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. The company's lead program is TTI-621, a SIRPaFc fusion protein that acts a soluble decoy receptor preventing CD47 from delivering its inhibitory signal, which is in Phase I clinical trial for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. Its product candidates also include TTI-622 that is in Phase I clinical trial of immunoglobulin G4 SIRPaFc protein; and TTI-10001, a small molecule stimulator of interferon genes agonist that senses cytosolic DNA for promoting tumor immunity, which is in the discovery Phase. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was founded in 2004 is headquartered in Mississauga, Canada.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| JMP Securities | Market Perform | Market Outperform | 24 авг 2021 г. |
| Craig-Hallum | Hold | Buy | 24 авг 2021 г. |
| HC Wainwright & Co. | Neutral | Buy | 23 авг 2021 г. |
| Benchmark | Buy | 14 апр 2021 г. | |
| HC Wainwright & Co. | Buy | Buy | 18 ноя 2020 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Walker Paul Edward | D | 0 | 40000 | 17 ноя 2021 г. |
| Walker Paul Edward | D | 0 | 40000 | 17 ноя 2021 г. |
| Walker Paul Edward | D | 0 | 40000 | 17 ноя 2021 г. |
| Walker Paul Edward | D | 0 | 40000 | 17 ноя 2021 г. |
| Walker Paul Edward | D | 0 | 40000 | 17 ноя 2021 г. |
| Myers Scott Dunseth | D | 0 | 67000 | 17 ноя 2021 г. |
| Pucci Paolo | D | 0 | 67000 | 17 ноя 2021 г. |
| BESHAR LUKE M | D | 0 | 547656 | 17 ноя 2021 г. |
| BESHAR LUKE M | D | 0 | 547656 | 17 ноя 2021 г. |
| Harrison Rosemary | D | 0 | 180000 | 17 ноя 2021 г. |
Новостная лента
MDA Breakout Stocks/ETFs Week 12 - March 2023: High-Frequency Gainers To Give You An Edge
Seeking Alpha
19 мар 2023 г. в 07:43
Two new Breakout Stocks for Week 12 with better than 10% short-term upside with ETFs and a Dow 30 Pick. Average cumulative returns for 2023 are +37.3% YTD. The Momentum Gauges® continue negative in bear funds from Mar 7th led by BNKD +65.7%. EGO peaked at +8.3% gains for members.
Week 27 MDA Breakout Stocks - July 2022: Short-Term Picks To Give You An Edge
Seeking Alpha
05 июл 2022 г. в 10:57
Two new Breakout Stocks for Week 27 with better than 10% short-term upside potential and a Dow 30 Pick. Average cumulative returns now down to +85.6% YTD.
Week 15 MDA Breakout Stocks - April 2022: Short-Term Picks To Give You An Edge
Seeking Alpha
10 апр 2022 г. в 06:12
Week 15 MDA Breakout Stocks - April 2022: Short-Term Picks To Give You An Edge
Week 13 MDA Breakout Stocks - April 2022: Short-Term Picks To Give You An Edge
Seeking Alpha
28 мар 2022 г. в 06:13
Two sample Breakout Stocks for Week 13 with better than 10% short-term upside potential and a Dow stock pick.
Week 11 MDA Breakout Stocks - March 2022: Short-Term Picks To Give You An Edge
Seeking Alpha
13 мар 2022 г. в 04:42
Week 11 MDA Breakout Stocks - March 2022: Short-Term Picks To Give You An Edge